Submitted for Publication: July 29, 2011; final revision received April 6, 2012; accepted April 10, 2012.
Published Online: July 2, 2012. doi:10.1001/archgenpsychiatry.2012.592
Author Contributions: All authors had full access to all the data in the study. Dr Kessler takes responsibility for the integrity of the data and the accuracy of the data analysis.
Conflict of Interest Disclosures: Dr Kessler has been a consultant for Analysis Group, Inc, AstraZeneca, Bristol-Myers Squibb, Cerner-Galt Associates, Eli Lilly & Company, GlaxoSmithKline Inc, HealthCore Inc, Health Dialog, Integrated Benefits Institute, John Snow Inc, Kaiser Permanente, Matria Inc, Mensante, Merck & Co, Inc, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, Primary Care Network, Research Triangle Institute, sanofi-aventis Groupe, Shire US Inc, SRA International Inc, Takeda Global Research & Development, Transcept Pharmaceuticals Inc, and Wyeth-Ayerst; has served on advisory boards for Appliance Computing II, Eli Lilly & Company, Mindsite, Ortho-McNeil Janssen Scientific Affairs, Plus One Health Management, and Wyeth-Ayerst; and has had research support for epidemiologic studies from Analysis Group, Inc, Bristol-Myers Squibb, Eli Lilly & Company, EPI-Q, GlaxoSmithKline, Johnson & Johnson Pharmaceuticals, Ortho-McNeil Janssen Scientific Affairs, Pfizer Inc, sanofi-aventis Groupe, and Shire US Inc.
Funding/Support: The NCS-A is supported by National Institute of Mental Health (NIMH) grants U01-MH60220 and R01-MH66627, with supplemental support from the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration, grant 044780 from the Robert Wood Johnson Foundation, and the John W. Alden Trust. Preparation of this manuscript was also supported by NIMH grants K01-MH092526 (Dr McLaughlin) and K01-MH085710 (Dr Green). The World Mental Health (WMH) Data Coordination Centres have received support from NIMH grants R01-MH070884, R13-MH066849, R01-MH069864, and R01-MH077883; NIDA grant R01-DA016558; the Fogarty International Center of the National Institutes of Health grant R03-TW006481; the John D. and Catherine T. MacArthur Foundation; the Pfizer Foundation; and the Pan American Health Organization. The WMH Data Coordination Centres have also received unrestricted educational grants from AstraZeneca, Bristol-Myers Squibb, Eli Lilly & Company, GlaxoSmithKline, Ortho-McNeil, Pfizer, sanofi-aventis, and Wyeth.
Role of the Sponsors: The sponsors had no role in the design and conduct of the study; the collection, management, analysis, and interpretation of the data; and the preparation, review, or approval of the manuscript.
Disclaimer: The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of any of the sponsoring organizations, agencies, or US government.
Additional Contributions: The staff of the WMH Data Collection and Data Analysis Coordination Centres assisted with instrumentation, fieldwork, and consultation on data analysis.